Oncogenic CDK13 mutations impede nuclear RNA surveillance
Published version of a preprint
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
RNA surveillance pathways detect and degrade defective transcripts to ensure RNA fidelity. We found that disrupted nuclear RNA surveillance is oncogenic. Cyclin-dependent kinase 13 ( CDK13 ) is mutated in melanoma, and patient-mutated CDK13 accelerates zebrafish melanoma. CDK13 mutation causes aberrant RNA stabilization. CDK13 is required for ZC3H14 phosphorylation, which is necessary and sufficient to promote nuclear RNA degradation. Mutant CDK13 fails to activate nuclear RNA surveillance, causing aberrant protein-coding transcripts to be stabilized and translated. Forced aberrant RNA expression accelerates melanoma in zebrafish. We found recurrent mutations in genes encoding nuclear RNA surveillance components in many malignancies, establishing nuclear RNA surveillance as a tumor-suppressive pathway. Activating nuclear RNA surveillance is crucial to avoid accumulation of aberrant RNAs and their ensuing consequences in development and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this context, it was recently shown that oncogenic mutations in one of the cyclin-dependent protein kinases (CDK13) impair the function of cofactors of the nuclear RNA exosome, specifically ZC3H18 and SKIV2L2, resulting in deficiencies in nuclear RNA surveillance and RNA exosome activity57.”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [57]
In the citing paper
“ZC3H14 phosphorylation regulates its association with PAXT and promotes the nuclear degradation of transcripts that are prematurely terminated during RNA polymerase II transcription [34].”
From Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance (2025) · cites this paper as [34]
In the citing paper
“Our RNA-seq data are consistent with previous transcriptome-wide analyses that revealed that a ZC3H14 deficiency shows very few significant expression changes [34, 51].”
From Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance (2025) · cites this paper as [34]
In the citing paper
“We note, however, that siRNA-mediated depletion of ZC3H14 revealed few changes in ptRNA expression, whereas a phospho-mimetic version of ZC3H14 showed more impact on the expression of ptRNAs [34].”
From Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance (2025) · cites this paper as [34]
In the citing paper
“It is therefore likely that the activity of ZC3H14 as a positive [34] and negative (our study) regulator of nuclear RNA turnover is controlled by phosphorylation.”
From Antagonistic roles by the conserved nuclear poly(A)-binding proteins PABPN1 and ZC3H14 in nuclear RNA surveillance (2025) · cites this paper as [34]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Self-citationGenomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Hoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., Shen, R., Taylor, A. M., Cherniack, A. D., Thorsson, V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.022 · Cited by 2,546 · cited 12×
“The percentages of CDK13altered (mutated or down-regulated) melanomas with BRAF mutations or NRAS were compared with the remaining cases in the TCGA melanoma cohort (24), and no significant differences were found (chi-square test, P = 0.”
BackgroundMethodInfluentialDECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M., Rajan, D., Vooren, S. V., Moreau, Y., Pettett, R. M., & Carter, N. P. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.010 · Cited by 1,990
Detecting differential usage of exons from RNA-seq data
Anders, S., Reyes, A., & Huber, W. (2012) · Genome Research · doi:10.1101/gr.133744.111 · Cited by 1,545
Prevalence and architecture of de novo mutations in developmental disorders
Study, D. D. D. (2017) · Nature · doi:10.1038/nature21062 · Cited by 1,480
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
Liu, D., Schilling, B., Liu, D., Sucker, A., Livingstone, E., Jerby-Arnon, L., Zimmer, L., Gutzmer, R., Satzger, I., Loquai, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0654-5 · Cited by 1,039
Self-citationLoss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.033 · Cited by 789
Self-citationThe histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Ceol, C. J., Houvras, Y., Jane-Valbuena, J., Bilodeau, S., Orlando, D. A., Battisti, V., Fritsch, L., Lin, W. M., Hollmann, T. J., Ferré, F., et al. (2011) · Nature · doi:10.1038/nature09806 · Cited by 542
Self-citationNon-canonical functions of cell cycle cyclins and cyclin-dependent kinases
Hydbring, P., Malumbres, M., & Sicinski, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.27 · Cited by 528 · cited 1×
“T ranscriptional cyclin-dependent kinases (CDKs) are a family of kinases activated by a cyclin-binding partner (1, 2) that have roles in controlling transcriptional subprocesses including initiation, elongation, co-transcriptional RNA processing, and termination (3–9).”
BackgroundBlazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J., & Peterlin, B. M. (2011) · Genes & Development · doi:10.1101/gad.16962311 · Cited by 522 · cited 1×
“RNA signature No loss of DNA repair gene expression Loss of DNA repair gene expression (7, 8, 40, 66) .”
BackgroundViswanathan, S. R., Ha, G., Hoff, A. M., Wala, J. A., Carrot-Zhang, J., Whelan, C. W., Haradhvala, N. J., Freeman, S. S., Reed, S. C., Rhoades, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.036 · Cited by 365 · cited 1×
“9%), cancer cell lines (8%) Prostate, ovarian (64, 65) .”
BackgroundCDK12 regulates DNA repair genes by suppressing intronic polyadenylation
Dubbury, S. J., Boutz, P. L., & Sharp, P. A. (2018) · Nature · doi:10.1038/s41586-018-0758-y · Cited by 318 · cited 4×
“RNA signature No loss of DNA repair gene expression Loss of DNA repair gene expression (7, 8, 40, 66) .”
BackgroundInfluentialSelf-citationIdentification of a Nuclear Exosome Decay Pathway for Processed Transcripts
Meola, N., Domanski, M., Karadoulama, E., Chen, Y., Gentil, C., Pultz, D., Vitting-Seerup, K., Lykke-Andersen, S., Andersen, J. S., Sandelin, A., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.025 · Cited by 290 · cited 3×
“4C), both PABPN1 and ZC3H14 interact with the polyA tail eXosome Targeting (PAXT) complex (22), which is responsible for targeting ptRNAs for degradation (23).”
BackgroundKrajewska, M., Dries, R., Grassetti, A. V., Dust, S., Gao, Y., Huang, H., Sharma, B., Day, D. S., Kwiatkowski, N., Pomaville, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09703-y · Cited by 281 · cited 3×
“RNA signature No loss of DNA repair gene expression Loss of DNA repair gene expression (7, 8, 40, 66) .”
BackgroundSelf-citationCDK13 cooperates with CDK12 to control global RNA polymerase II processivity
Fan, Z., Devlin, J. R., Hogg, S. J., Doyle, M. A., Harrison, P. F., Todorovski, I., Cluse, L. A., Knight, D. A., Sandow, J. J., Gregory, G., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz5041 · Cited by 164 · cited 1×
“Loss of both alleles is infrequently observed, possibly because of reduced cellular fitness, as was seen for a cancer cell line (59).”
BackgroundSelf-citationStructural and functional analysis of the Cdk13/Cyclin K complex
Greifenberg, A. K., Hönig, D., Pilarova, K., Düster, R., Bartholomeeusen, K., Bösken, C. A., Anand, K., Blazek, D., & Geyer, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.025 · Cited by 157
Self-citationHamilton, M. J., Caswell, R. C., Canham, N., Cole, T., Firth, H. V., Foulds, N., Heimdal, K., Hobson, E., Houge, G., Joss, S., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104620 · Cited by 43
Research works printed but not linked: 65
- 10.1186/gb4184 · DOI · Paper page
- 10.1038/nrg3293 · DOI · Paper page
- 10.1101/gad.11.24.3306 · DOI · Paper page
- 10.1128/MCB.23.19.6876-6886.2003 · DOI
- 10.1101/gad.999002 · DOI · Paper page
- 10.1101/gad.341545.120 · DOI
- 10.1016/j.cell.2014.10.024 · DOI · Paper page
- 10.1016/j.ccell.2014.10.019 · DOI · Paper page
- 10.1038/nature13393 · DOI · Paper page
- 10.1016/j.cell.2015.08.063 · DOI · Paper page
- 10.1016/j.xcrm.2020.100188 · DOI
- 10.1038/ng.3627 · DOI · Paper page
- 10.1111/cge.13225 · DOI
- 10.1186/s13073-017-0463-8 · DOI · Paper page
- 10.1093/nar/gks1327 · DOI
- 10.1155/2013/846510 · DOI
- 10.1101/gad.302604.117 · DOI · Paper page
- 10.1056/NEJMoa1406498 · DOI · Paper page
- 10.1158/2159-8290.CD-13-0617 · DOI · Paper page
- 10.1038/nature22071 · DOI · Paper page
- 10.1093/nar/gks743 · DOI · Paper page
- 10.1073/pnas.90.2.442 · DOI · Paper page
- 10.1126/science.aau6509 · DOI · Paper page
- 10.1016/j.cub.2005.01.031 · DOI · Paper page
- 10.1128/MCB.01426-14 · DOI · Paper page
- 10.1074/jbc.M111.321760 · DOI
- 10.1126/science.aad9841 · DOI · Paper page
- 10.1016/j.celrep.2018.04.061 · DOI · Paper page
- 10.1074/jbc.M410051200 · DOI · Paper page
- 10.1074/jbc.M206494200 · DOI · Paper page
- 10.1038/75556 · DOI · Paper page
- 10.1016/j.celrep.2020.01.068 · DOI · Paper page
- 10.1073/pnas.1107103108 · DOI · Paper page
- 10.1093/hmg/ddx248 · DOI · Paper page
- 10.1038/nmeth1048 · DOI · Paper page
- 10.1093/nar/gky446 · DOI · Paper page
- 10.3389/fcell.2019.00155 · DOI
- 10.1093/nar/gkt958 · DOI · Paper page
- 10.3389/fgene.2022.858668 · DOI
- 10.1038/s41586-018-0465-8 · DOI · Paper page
- 10.1016/j.molcel.2019.08.007 · DOI · Paper page
- 10.1038/s41586-019-1651-z · DOI · Paper page
- 10.1016/j.ajhg.2015.05.021 · DOI
- 10.1038/nature10166 · DOI · Paper page
- 10.1093/nar/gkv101 · DOI · Paper page
- 10.1093/nar/gkv101 · DOI · Paper page
- 10.1038/nmeth0410-248 · DOI · Paper page
- 10.1093/nar/gkr407 · DOI · Paper page
- 10.1158/2159-8290.CD-12-0095 · DOI · Paper page
- 10.1093/bioinformatics/btp352 · DOI · Paper page
- 10.1093/bioinformatics/btu638 · DOI · Paper page
- 10.1073/pnas.1307202110 · DOI · Paper page
- 10.1038/nbt.1754 · DOI · Paper page
- C. K. Kaufman C. Mosimann Z. P. Fan S. Yang A. J. Thomas J. Ablain J. L. Tan R. D. Fogley E. van Rooijen E. J. Hagedorn C. Ciarlo R. M. White D. A. Matos A.-C. Puller C. Santoriello E. C. Liao R. A. Young L. I. Zon A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science 351 aad2197 (2016). 10.1126/science.aad219726823433 · DOI · Paper page
- 10.1093/nar/gkw398 · DOI · Paper page
- 10.1093/nar/gku410 · DOI · Paper page
- 10.1038/nprot.2006.98 · DOI · Paper page
- 10.1186/gb-2009-10-3-r25 · DOI · Paper page
- 10.1186/gb-2013-14-4-r36 · DOI · Paper page
- 10.1038/nprot.2012.016 · DOI · Paper page
- 10.1093/bioinformatics/bts635 · DOI · Paper page
- 10.1093/bioinformatics/btq033 · DOI · Paper page
- 10.1371/journal.pone.0006529 · DOI · Paper page
- 10.1038/nbt.3519 · DOI · Paper page
- 10.1126/science.1231143 · DOI · Paper page
Cited by
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 304
Latour, M., Kwiatek, L., Landry-Voyer, A.-M., & Bachand, F. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf060 · Cited by 10
Kuliński, T. M., Gewartowska, O., Mahé, M., Kasztelan, K., Durys, N., Stroynowska-Czerwińska, A., Jedynak-Slyvka, M., Owczarek, E. P., Chaudhury, D., Nowotny, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70386-3 · Cited by 7
Metadata
- Authors
- Insco, M. L., Abraham, B. J., Dubbury, S. J., Kaltheuner, I. H., Dust, S., Wu, C., Chen, K. Y., Liu, D., Bellaousov, S., Cox, A. M., Martin, B. J. E., Zhang, T., Ludwig, C. G., Fabo, T., Modhurima, R., Esgdaille, D. E., Henriques, T., Brown, K. M., Chanock, S. J., Geyer, M., Adelman, K., Sharp, P. A., Young, R. A., Boutz, P. L., & Zon, L. I.
- Venue
- Science
- Published
- 2023-04-21
- Volume
- 380
- Issue
- 6642
- ISSN
- 0036-8075
- 1095-9203
- Cited by
- 74
- References
- 21
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.